Laura Bush
Medical · Fayetteville, GANPI 1174565022
Payments from drug & device makers
Across 1,044 payments — averaging $140.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$39K
- UCB, Inc.$19K
- Boehringer Ingelheim$12K
- Arcutis Biotherapeutics, Inc.$11K
- Incyte Corporation$11K
- Novartis$10K
- plus $44K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 102 | $39,304 |
| UCB, Inc. | 102 | $19,487 |
| Boehringer Ingelheim | 14 | $11,733 |
| Arcutis Biotherapeutics, Inc. | 43 | $11,199 |
| Incyte Corporation | 51 | $11,070 |
| Novartis | 103 | $9,600 |
| Dermavant Sciences, Inc. | 39 | $8,867 |
| E.r. Squibb & Sons, L.L.C. | 108 | $7,073 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $5,406 |
| Sanofi | 65 | $3,458 |
| Amgen | 65 | $3,210 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $2,894 |
| AbbVie | 116 | $2,528 |
| Eli Lilly | 1 | $2,100 |
| Galderma Laboratories, L.p. | 28 | $1,757 |
| Regeneron Healthcare Solutions, Inc. | 53 | $1,699 |
| LEO Pharma Inc. | 15 | $1,064 |
| Lilly USA, LLC | 36 | $890 |
| Organon | 10 | $843 |
| Almirall LLC | 12 | $556 |
| Pfizer | 20 | $505 |
| Sun Pharmaceutical Industries Inc. | 12 | $326 |
| Sanofi-aventis U.S. LLC | 2 | $187 |
| Helsinn Therapeutics (U.S.), Inc. | 10 | $178 |
| Genentech USA, Inc. | 6 | $130 |
| Mayne Pharma Commercial LLC | 6 | $92 |
| Kerecis Limited | 2 | $41 |
| Bausch Health US, LLC | 1 | $36 |
| Organogenesis Inc. | 1 | $30 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $18 |
How this compares
$146,302 in reported general payments places this provider in the 95th percentile of 950 medical providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Fayetteville
- Dawn PalettaFayetteville$11K
- Amber MayfieldFayetteville$10K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Felicia HoffmanRoswell$114K
- Sally BrumbillLithia Springs$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.